CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Patricia Dias Fernandes

ORCID: 0000-0001-6870-6745↗

Public evidence

4 connected articles

Novel Multifunctional Cannabidiol-Based Analogues with In Silico, In Vitro, and In Vivo Anti-SARS-CoV-2 Effect.2025 · Europe PMC 2-Arylpropionic Acid Pyrazolamides as Cannabinoid CB2 Receptor Inverse Agonists Endowed with Anti-Inflammatory Properties.2022 · Europe PMC Two New <sup>β</sup><i>N</i>-Alkanoyl-5-Hydroxytryptamides with Relevant Antinociceptive Activity.2021 · Europe PMC New <sup>β</sup>N-octadecanoyl-5-hydroxytryptamide: antinociceptive effect and possible mechanism of action in mice.2018 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Patricia Dias Fernandes - Medical Cannabis Research Engine